Nine Public Companies Sell 72% of Florida's Medical Cannabis. Two Will Say What Florida Earns Them.
The state publishes every operator's Florida volume every week. Their quarterly filings mostly don't. Here is what each listed company discloses about Florida, set against five weeks of the state's own data.
Florida's Office of Medical Marijuana Use publishes, every Friday, how much THC and how much smokable flower each licensed company dispensed that week, and from how many stores.
The companies' own reports are not. Nine publicly traded companies run dispensaries in Florida. Across the five weeks from 11 September to 15 October, their stores dispensed 72.2% of all the THC sold in the state. Only two of them — FLUENT Corp. and Vireo Growth — put a dollar figure on what Florida earned them last quarter.
The listed companies, side by side
| Company | Ticker | Florida stores | Share of Florida THC, 5 weeks | THC per store vs state average | Q2 2026 total revenue | Florida revenue disclosed? |
|---|---|---|---|---|---|---|
| Trulieve | NYSE: TRLV | 170 | 26.2% | +21% | $271.0M | No |
| Verano (MÜV) | Cboe CA / OTCQX: VRNO | 86 | 11.8% | +7% | $217.9M | No |
| Curaleaf | TSX: CURA · OTCQX: CURLF | 79 | 11.4% | +13% | $340.1M | No |
| Green Thumb (Rise) | CSE: GTII · OTCQX: GTBIF | 26 | 5.1% | +60% | $306.7M | No |
| FLUENT Corp. | CSE: FNT.U · OTCQB: CNTMF | 33 | 4.8% | +13% | $17.1M | Yes — $12.8M |
| Vireo Growth (Green Dragon) | CSE: VREO · OTCQX: VREOF | 41 | 4.7% | −9% | $209.3M | Yes — $9.5M retail |
| iAnthus (GrowHealthy) | CSE: IAN · OTC: ITHUF | 26 | 3.2% | −5% | $35.3M | Changes only |
| Cresco Labs (Sunnyside) | CSE: CL · OTCQX: CRLBF | 31 | 2.5% | −37% | $173.3M | No |
| Planet 13 | CSE: PLTH · OTCQX: PLNH | 34 | 2.5% | −44% | $22.9M | Growth rate only |
Store counts are the state's, for the week of 9–15 October 2026. Revenue is each company's total for the quarter ended 30 June 2026, in US dollars. Volume shares and per-store figures are milligrams of THC from the OMMU weekly tables, 11 September – 15 October 2026; the state average over those five weeks was 538,563 mg per store per week.
The two that put a number on it
FLUENT is the one listed company that reports most of its revenue as Florida revenue — $12.8 million of its $17.1 million — and its Florida number is going the wrong way. Florida revenue was $12.8 million in the second quarter, against $19.2 million a year earlier — down a third. The company reported a net loss of $11.1 million and $79.7 million of debt, and its filings warn of circumstances that "may cast significant doubt" on its ability to continue as a going concern. It stopped cultivation at its Ruskin, Florida facility on 1 April.
FLUENT is merging into Vireo. Shareholders approved the deal on 28 July; as of mid-October it had not closed, and the company expects it to close in the fourth quarter. In the state's data, FLUENT's 33 stores still sell 13% more THC per door than the average.
Vireo entered Florida on 1 April, when it completed its merger with Eaze and took over the Green Dragon stores. Its second-quarter results include a state-by-state table: Florida retail revenue was $9.5 million, its first full quarter in the state. In the state's data, Green Dragon's 41 stores sell 9% less THC per store than the average.
Vireo is also buying Planet 13. With FLUENT and Planet 13, it would control 108 Florida stores and, on the last five weeks, 12.0% of the state's THC — second to Trulieve by store count.
The ones that describe Florida without a number
iAnthus reports Florida inside a segment with Arizona and Massachusetts, but its quarterly report gives the direction of travel: Florida revenue fell $0.2 million in the quarter "due to continued competitive pressures," and $2.9 million over the first half; Florida gross profit fell $4.7 million over the half. The same filing carries a going-concern warning.
Planet 13 said in its second-quarter results that "Florida revenue increased 17.1% quarter over quarter", while blaming part of its overall 14.9% revenue decline on "continued price compression in Nevada and Florida." Vireo's S-4 for the merger says that if the deal fails, Planet 13 "has substantial doubt about its ability to raise financing sufficient to continue operating as a going concern." In the state's data its stores sell 44% less THC per store than the average.
Cresco Labs names Florida once in its second-quarter report: first-half revenue fell on "increased competition, price compression, and price discounting in the Illinois, Florida, and Pennsylvania markets." When it opened its 31st Florida store in January, its chief executive called Florida "the largest medical market in the country." Its Sunnyside stores sell 37% less THC per store than the state average.
Green Thumb credits Florida as a growth market — revenue rose on "continued growth in existing markets, particularly in Connecticut, Florida and Ohio" — without a Florida figure. It doesn't need one to make the point: its Rise stores sell 60% more THC per store than the state average, the second-highest of any operator over the five weeks. It opened its 26th Florida store, in Belleview, on 16 October.
The biggest say the least
Trulieve runs 170 of Florida's 782 dispensaries — 21.7% of the state's doors — and dispensed 26.2% of the state's THC over the five weeks. Its second-quarter revenue was $271.0 million. Its investor presentation gives "Medical only revenue $222 million", but that figure combines Florida with Georgia, Pennsylvania and West Virginia. The same presentation claims a 35% share of Florida's flower market; in the state's data for the five weeks, Trulieve's share of smokable flower was 34.0%.
Verano runs 86 MÜV stores in Florida and reported $217.9 million of revenue with no Florida breakdown. Its quarterly report lists $21.7 million of assets held for sale related to cultivation facilities in Florida and Massachusetts, without separating the two.
Curaleaf reports only "Domestic" and "International" segments. Its $340.1 million of second-quarter revenue includes 79 Florida stores, a footprint it has been growing all year, most recently in Wellington.
Two Florida chains that no longer answer to public shareholders
Ayr — 65 stores, 8.8% of the state's THC over the five weeks — still trades under the Ayr Wellness name in Florida, but its Florida business was transferred on 2 June 2026 to Arboretum, an entity set up by its senior secured noteholders. The former listed parent is being wound down in a Canadian insolvency proceeding.
Surterra — 43 stores — sits with lenders too. Its parent, Parallel, handed its Florida, Texas and Massachusetts operations to a creditor vehicle in July. Nasdaq-listed SNDL has indirect majority economic exposure to that vehicle, and on 15 October raised its indirect interest in Parallel from about 67% to about 92%. It describes "potential future pathways toward integration" of Parallel's medical cannabis operations but does not yet consolidate or report Florida results. In the state's data, Surterra sells the least THC per store of any large chain: 58% below the average.
What to watch
Third-quarter results start arriving this month: SNDL on 27 October, Verano on 29 October, Curaleaf on 3 November, Green Thumb on 4 November, Trulieve on 5 November and Cresco on 6 November. If the pattern holds, most of them will say little about Florida. The state will keep publishing every Friday.
